169 related articles for article (PubMed ID: 25548320)
1. C-reactive protein enhances IgG-mediated phagocyte responses and thrombocytopenia.
Kapur R; Heitink-Pollé KM; Porcelijn L; Bentlage AE; Bruin MC; Visser R; Roos D; Schasfoort RB; de Haas M; van der Schoot CE; Vidarsson G
Blood; 2015 Mar; 125(11):1793-802. PubMed ID: 25548320
[TBL] [Abstract][Full Text] [Related]
2. The isotype of autoantibodies influences the phagocytosis of antibody-coated platelets in autoimmune thrombocytopenic purpura.
Hoemberg M; Stahl D; Schlenke P; Sibrowski W; Pachmann U; Cassens U
Scand J Immunol; 2011 Nov; 74(5):489-95. PubMed ID: 21790706
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein boosts antibody-mediated platelet destruction.
Semple JW
Blood; 2015 Mar; 125(11):1690-1. PubMed ID: 25766565
[No Abstract] [Full Text] [Related]
4. Recognition of the human antibody-mediated platelet destruction in adult ITP patients by C-reactive protein.
Pan JQ; Wang W; Wang ML; Li XY; Wang JH; Zhao WW; Tian YY; Dong XS; Jiang YF
Int J Clin Exp Pathol; 2017; 10(10):10176-10185. PubMed ID: 31966351
[TBL] [Abstract][Full Text] [Related]
5. C-Reactive Protein Enhances IgG-Mediated Cellular Destruction Through IgG-Fc Receptors
Temming AR; Tammes Buirs M; Bentlage AEH; Treffers LW; Feringa H; de Taeye SW; Kuijpers TW; Nagelkerke SQ; Brasser G; Mok JY; van Esch WJE; van den Berg TK; Rispens T; van der Schoot CE; Vidarsson G
Front Immunol; 2021; 12():594773. PubMed ID: 33790888
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte-macrophage colony-stimulating factor (GM-CSF) in children with acute immune thrombocytopenic purpura.
Rizk EA; El-Gendy WM; Hassab H; El-Madboully L
Med Sci Monit; 2004 Jul; 10(7):CR330-5. PubMed ID: 15232508
[TBL] [Abstract][Full Text] [Related]
7. Exacerbation of autoantibody-mediated thrombocytopenic purpura by infection with mouse viruses.
Musaji A; Cormont F; Thirion G; Cambiaso CL; Coutelier JP
Blood; 2004 Oct; 104(7):2102-6. PubMed ID: 15205264
[TBL] [Abstract][Full Text] [Related]
8. Current therapies in primary immune thrombocytopenia.
Pels SG
Semin Thromb Hemost; 2011 Sep; 37(6):621-30. PubMed ID: 22102265
[TBL] [Abstract][Full Text] [Related]
9. Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro.
Iraqi M; Perdomo J; Yan F; Choi PY; Chong BH
Haematologica; 2015 May; 100(5):623-32. PubMed ID: 25682608
[TBL] [Abstract][Full Text] [Related]
10. Tetramolecular immune complexes are more efficient than IVIg to prevent antibody-dependent in vitro and in vivo phagocytosis of blood cells.
Bazin R; Lemieux R; Tremblay T; St-Amour I
Br J Haematol; 2004 Oct; 127(1):90-6. PubMed ID: 15384982
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia.
Teeling JL; Jansen-Hendriks T; Kuijpers TW; de Haas M; van de Winkel JG; Hack CE; Bleeker WK
Blood; 2001 Aug; 98(4):1095-9. PubMed ID: 11493456
[TBL] [Abstract][Full Text] [Related]
12. Sequestration of anti-platelet GPIIIa antibody in rheumatoid factor immune complexes of human immunodeficiency virus 1 thrombocytopenic patients.
Karpatkin S; Nardi MA; Hymes KB
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2263-7. PubMed ID: 7892259
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.
Samuelsson A; Towers TL; Ravetch JV
Science; 2001 Jan; 291(5503):484-6. PubMed ID: 11161202
[TBL] [Abstract][Full Text] [Related]
14. Role of Fcgamma receptors in the pathogenesis and treatment of idiopathic thrombocytopenic purpura.
Crow AR; Lazarus AH
J Pediatr Hematol Oncol; 2003 Dec; 25 Suppl 1():S14-8. PubMed ID: 14668633
[TBL] [Abstract][Full Text] [Related]
15. In-vitro inhibition of antiplatelet autoantibodies by intravenous immunoglobulins and Rh immunoglobulins.
Mehta YS; Badakere SS
J Postgrad Med; 1996; 42(2):46-9. PubMed ID: 9715299
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG.
Song S; Crow AR; Freedman J; Lazarus AH
Blood; 2003 May; 101(9):3708-13. PubMed ID: 12506021
[TBL] [Abstract][Full Text] [Related]
17. Platelet activation induced by an antiplatelet autoantibody against CD9 antigen and its inhibition by another autoantibody in immune thrombocytopenic purpura.
Yanabu M; Nomura S; Fukuroi T; Suzuki M; Kawakatsu T; Kido H; Yamaguchi K; Kokawa T; Yasunaga K
Br J Haematol; 1993 Aug; 84(4):694-701. PubMed ID: 8217830
[TBL] [Abstract][Full Text] [Related]
18. Thiazolidinediones increase the number of platelets in immune thrombocytopenic purpura mice via inhibition of phagocytic activity of the reticulo-endothelial system.
Kasono K; Nishida J; Tamemoto H; Fudaka K; Namai K; Kajio H; Masatoshi K; Kanazawa Y; Kawakami M
Life Sci; 2002 Sep; 71(17):2037-52. PubMed ID: 12175897
[TBL] [Abstract][Full Text] [Related]
19. Critical role of CD4(+)CD25(+) regulatory T cells in preventing murine autoantibody-mediated thrombocytopenia.
Nishimoto T; Satoh T; Takeuchi T; Ikeda Y; Kuwana M
Exp Hematol; 2012 Apr; 40(4):279-89. PubMed ID: 22240606
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet antibody-induced thrombocytopenia does not correlate with megakaryocyte abnormalities in murine immune thrombocytopenia.
Guo L; Kapur R; Aslam R; Hunt K; Hou Y; Zufferey A; Speck ER; Rondina MT; Lazarus AH; Ni H; Semple JW
Scand J Immunol; 2018 Jul; 88(1):e12678. PubMed ID: 29855061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
